M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 5.08 EUR 4.53%
Market Cap: 81.9m EUR

Wall Street
Price Targets

MAAT Price Targets Summary
Maat Pharma SA

Wall Street analysts forecast MAAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAAT is 18.53 EUR with a low forecast of 15.66 EUR and a high forecast of 23.1 EUR.

Lowest
Price Target
15.66 EUR
208% Upside
Average
Price Target
18.53 EUR
265% Upside
Highest
Price Target
23.1 EUR
355% Upside
Maat Pharma SA Competitors:
Price Targets
IGMS
IGM Biosciences Inc
39% Upside
2696
Shanghai Henlius Biotech Inc
23% Downside
1952
Everest Medicines Ltd
20% Upside
APGE
Apogee Therapeutics Inc
153% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
38% Upside
VIR
Vir Biotechnology Inc
560% Upside
6955
Shandong Boan Biotechnology Co Ltd
12% Downside
ANAB
AnaptysBio Inc
69% Upside

Revenue
Forecast

Revenue Estimate
Maat Pharma SA

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 166%.

N/A
Past Growth
166%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Maat Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Maat Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MAAT's stock price target?
Price Target
18.53 EUR

According to Wall Street analysts, the average 1-year price target for MAAT is 18.53 EUR with a low forecast of 15.66 EUR and a high forecast of 23.1 EUR.

What is Maat Pharma SA's Revenue forecast?
Projected CAGR
166%

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 166%.

Back to Top